The new tool can identify cases of ovarian cancer which are difficult to diagnose using standard methods. Read more
Researchers discovered that genetic mutations which fuel the growth of tumours often occur years before the cancer is discovered. Read more
Peripheral neuropathy is a common side effect of taxol chemotherapy, and a less common side effect of carboplatin, both used to treat ovarian cancer. Read more
Researchers at Cardiff University have discovered a part of our immune system which could be used to treat all cancers, including ovarian cancer. Read more
News from the ESMO (European Society for Medical Oncology) 2019 conference Read more
The randomised trial of a drug called trametinib – previously used to treat melanoma – was shown to have an increased response rate compared with standard treatments. Read more
Researchers from Queen’s University Belfast have developed a test that may be able to detect ovarian cancer up to two years earlier than current approaches. Read more
The new drug can get inside tumour cells and has shown promise in patients with six different advanced, drug-resistant cancers. Read more
The test scans the shapes of tumour cells to pick out women with especially aggressive ovarian cancer, so treatment can be tailored to their needs. Read more
It is possible that preventing the webs from being formed could limit the spread and avoid the need for the omentum to be surgically removed Read more
Weight loss drug Orlistat may help women with treatment-resistant ovarian cancer respond to chemotherapy again. Read more
Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any type of ovarian cancer over the next decade than non-statin users. Read more
You can read the official record of the debate online. Read more
The results of the Phase III SOLO-1 trial have shown an increase in progression free survival for women with a BRCA mutation compared with a placebo. Read more
Researchers assessed the effect of three 90-minute sessions of psychological support on depression, fear of progression and quality of life. Read more
The drug could be suitable for women with ovarian cancer for whom chemotherapy has failed, and whose tumours have high levels of the alpha-folate receptor on the surface of cancer cells. Read more
However there are risks associated with aspirin use and anyone considering using it should discuss with their doctor. Read more
Among 11 evaluable cancer patients who had received more than the lowest dose of the vaccine, 6 had clinical benefit. Read more
A new study has been published, looking into why some patients respond to PARP inhibitors while others do not. Read more
This supports previous findings for the risk-reducing effect of older forms of the combined pill. Read more
The Department today announced plans to improve access to innovative new medicines for cancers and other conditions. Read more
A simple urine test could diagnose ovarian cancer at early stages. Read more
UCLH Cancer Collaborative is running a project focused on avoiding late diagnosis of ovarian cancer amongst BRCA carriers. Read more
Early trials are showing promising results for a combined chemotherapy and targeted treatment regime. Read more